Shengqiao Li

Biocompatibility evaluation of biosoluble stent coatings in a porcine coronary stent model

E. Verbeken, I. Scheerder, Yanming Huang, 2005 .

Long-term biocompatibility evaluation of poly-bis-trifluorethoxyphosphazene (PTFEP): a novel biodegradable polymer stent coating in a porcine coronary stent model

E. Verbeken, I. Scheerder, Xiaoshun Liu, 2005 .

Addition of cytochalasin D to a biocompatible oil stent coating inhibits intimal hyperplasia in a porcine coronary model

C. Vrints, J. Bosmans, E. Verbeken, 2003, Coronary artery disease.

HENOCH-SCHÖNLEIN PURPURA NEPHRITIS FOLLOWING INFLUENZA VACCINATION: A CASE REPORT AND REVIEW OF THE LITERATURE

Shengqiao Li, Qiang-song Wu, Jing-yi Liu, 2016, The Southeast Asian journal of tropical medicine and public health.

Stent‐based tempamine delivery on neointimal formation in a porcine coronary model

F. Van de Werf, Kwangdeok Lee, E. Verbeken, 2006, Acute cardiac care.

Long‐term biocompatibility evaluation of a novel polymer‐coated stent in a porcine coronary stent model

E. Verbeken, Xiaoshun Liu, I. D. de Scheerder, 2003, Coronary artery disease.

Local methylprednisolone delivery using a BiodivYsio phosphorylcholine-coated drug-delivery stent reduces inflammation and neointimal hyperplasia in a porcine coronary stent model

E. Verbeken, Xiaoshun Liu, I. D. de Scheerder, 2003, International journal of cardiovascular interventions.

Use of a tacrolimus-eluting stent to inhibit neointimal hyperplasia in a porcine coronary model.

F. Van de Werf, J. Bosmans, E. Verbeken, 2005, The Journal of invasive cardiology.

Methotrexate loaded SAE coated coronary stents reduce neointimal hyperplasia in a porcine coronary model

E. Verbeken, J. Bosmans, E. Verbeken, 2004, Heart.

Methotrexate loaded SAE coated coronary stents reduce neointimal hyperplasia in a porcine coronary model

E. Verbeken, I. Scheerder, Xiaoshun Liu, 2004, Heart.